GET /api/v0.1/hansard/entries/1493210/?format=api
HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"id": 1493210,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1493210/?format=api",
"text_counter": 51,
"type": "speech",
"speaker_name": "Endebess, UDA",
"speaker_title": "Hon. (Dr) Robert Pukose",
"speaker": null,
"content": " Hon. Deputy Speaker, I beg to move that the Kenya Drugs Authority Bill (National Assembly Bill No.54 of 2022) be now read a Third Time. I sponsored the Kenya Drugs Authority Bill (National Assembly Bill No.54 of 2022), which was published on 6th October 2022. It went through the First Reading on 3rd May 2023 and was thereafter committed to the Departmental Committee on Health for consideration. The Second Reading of the Bill was concluded on 18th October 2023. The Bill progressed to the Committee of the whole House, which was concluded yesterday, 6th November 2024. The Departmental Committee on Health, which I am privileged to chair had proposed amendments to improve the Bill, make it more effective, and address emerging issues such as parallel importation of health products and technologies, pharmacovigilance and sports market surveillance. Noting the pertinent importance of the Bill in promoting and guaranteeing the quality, safety, efficacy and effectiveness of health products and technologies in the country, seven Members, namely, Hon. Peter Kaluma, Hon. (Dr) Otiende Amollo, Hon. Millie Odhiambo, Hon. Irene Mayaka, Hon. Anthony Oluoch, Hon. (Dr) James Nyikal, and Hon. Martin Peters Owino proposed several amendments. This led to a winnowing process for purposes of harmonisation of the proposed amendments from Clause 23. That process culminated in the amendments that the Committee of the whole House considered and approved yesterday. I must commend my colleagues in the Departmental Committee on Health and other colleagues who took their time to propose amendments, and to participate in the winnowing process and in the Committee of the whole House. Their efforts have immensely improved the Bill for the benefit of all Kenyans and towards the progressive realisation of the right to the highest attainable standard of care guaranteed under Article 43 of the Constitution. I must restate that this Bill has re-engineered the current drugs regulator, the Pharmacy and Poisons Board, based on international best practices in regulation of human health products and technologies, and will move our country to Maturity Level 3. The Bill also fulfils the country’s obligation in the war against poor quality medicines in line with the commitment that Kenya made under the African Union (AU) Treaty for the Establishment of the African Medicines Agency that was ratified by this honourable House. I want to thank the Members who participated in the debate and who had a keen interest, especially the Leader of the Majority Party, Hon. Ichung’wah, and yourself, Madam Deputy Speaker, for prioritising this Bill to ensure that it saw the light of day. I also thank the Members who participated in the Committee of the whole House yesterday. I also thank the Member for Emuhaya who chaired the Committee of the whole House yesterday. I beg to move and ask Hon. Jaldesa to second."
}